Global Pharmaceutical Grade Polyethylene Glycol (PEG) Supply, Demand and Key Producers, 2026-2032
Description
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size is expected to reach $ 1291 million by 2032, rising at a market growth of 4.9% CAGR during the forecast period (2026-2032).
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is experiencing steady growth, driven by its widespread application in the pharmaceutical, biotechnology, and personal care industries. PEG is valued for its versatility, biocompatibility, and non-toxicity, making it an essential component in a variety of drug formulations.
1. Growth in the Biopharmaceutical Sector
PEGylation: PEG is widely used in biopharmaceuticals through a process known as PEGylation, where PEG chains are attached to therapeutic molecules like proteins or peptides to enhance their stability, reduce immunogenicity, and extend their half-life. With the increasing development of biologics and biosimilars, the demand for PEG in these applications is rising.
Monoclonal Antibodies and Proteins: The growing use of monoclonal antibodies (mAbs) and therapeutic proteins in treating chronic diseases like cancer, autoimmune disorders, and genetic conditions is driving demand for PEG, which helps improve the pharmacokinetics of these drugs.
2. Increasing Application in Drug Delivery Systems
Oral, Injectable, and Topical Formulations: PEG is commonly used in various drug delivery systems, including oral, injectable, and topical formulations. Its solubility and ability to improve drug bioavailability make it a preferred excipient in many pharmaceutical products. The rising demand for innovative drug delivery systems is boosting the PEG market.
Controlled and Sustained Release Formulations: PEG is also used in controlled-release formulations to enhance drug stability and modulate the release of active ingredients. As the pharmaceutical industry focuses on developing long-acting formulations, the role of PEG in these systems is expanding.
4. Expansion in the Pharmaceutical Industry
Pharmaceutical Excipients: PEG serves as an important excipient in a wide range of pharmaceutical formulations, including tablets, capsules, and ointments. Its role in improving drug solubility and absorption is critical, particularly for poorly soluble drugs. The continued growth of the pharmaceutical industry, driven by an aging population and the rise in chronic diseases, is contributing to increased demand for pharmaceutical-grade PEG.
Over-the-Counter (OTC) Medications: PEG is commonly used in laxatives and stool softeners. With the increase in the prevalence of gastrointestinal issues and other digestive disorders, particularly in developed markets, the demand for PEG-based OTC medications is growing.
5. Growing Focus on Sustainable and Bio-Based PEG
Sustainability Initiatives: There is an increasing trend toward using bio-based PEG derived from renewable resources due to growing environmental concerns and regulations. Manufacturers are focusing on developing eco-friendly, sustainable alternatives to traditional petrochemical-based PEG, which is expected to gain traction in the pharmaceutical and personal care industries.
Regulatory Compliance: With the tightening of environmental and safety regulations in several regions, the focus on green chemistry and sustainable production methods is becoming more important. Companies investing in the production of bio-based or biodegradable PEG will benefit from this shift.
This report studies the global Pharmaceutical Grade Polyethylene Glycol (PEG) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical Grade Polyethylene Glycol (PEG) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical Grade Polyethylene Glycol (PEG) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical Grade Polyethylene Glycol (PEG) total production and demand, 2021-2032, (Tons)
Global Pharmaceutical Grade Polyethylene Glycol (PEG) total production value, 2021-2032, (USD Million)
Global Pharmaceutical Grade Polyethylene Glycol (PEG) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Pharmaceutical Grade Polyethylene Glycol (PEG) consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Pharmaceutical Grade Polyethylene Glycol (PEG) domestic production, consumption, key domestic manufacturers and share
Global Pharmaceutical Grade Polyethylene Glycol (PEG) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Pharmaceutical Grade Polyethylene Glycol (PEG) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Pharmaceutical Grade Polyethylene Glycol (PEG) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Pharmaceutical Grade Polyethylene Glycol (PEG) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BASF, Dow Chemical, Croda, Clariant, Ineos, India Glycols, Shandong Ruisheng, Jiangxi Yipusheng, Liaoning Huaxing Chemical, Petronas Chemicals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical Grade Polyethylene Glycol (PEG) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market, Segmentation by Type:
Mw (＜1000)
Mw (1000-10000)
Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market, Segmentation by Application:
Tablets
Capsules
Liquids
Injectables
Topicals
Others
Companies Profiled:
BASF
Dow Chemical
Croda
Clariant
Ineos
India Glycols
Shandong Ruisheng
Jiangxi Yipusheng
Liaoning Huaxing Chemical
Petronas Chemicals
Key Questions Answered:
1. How big is the global Pharmaceutical Grade Polyethylene Glycol (PEG) market?
2. What is the demand of the global Pharmaceutical Grade Polyethylene Glycol (PEG) market?
3. What is the year over year growth of the global Pharmaceutical Grade Polyethylene Glycol (PEG) market?
4. What is the production and production value of the global Pharmaceutical Grade Polyethylene Glycol (PEG) market?
5. Who are the key producers in the global Pharmaceutical Grade Polyethylene Glycol (PEG) market?
6. What are the growth factors driving the market demand?
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is experiencing steady growth, driven by its widespread application in the pharmaceutical, biotechnology, and personal care industries. PEG is valued for its versatility, biocompatibility, and non-toxicity, making it an essential component in a variety of drug formulations.
1. Growth in the Biopharmaceutical Sector
PEGylation: PEG is widely used in biopharmaceuticals through a process known as PEGylation, where PEG chains are attached to therapeutic molecules like proteins or peptides to enhance their stability, reduce immunogenicity, and extend their half-life. With the increasing development of biologics and biosimilars, the demand for PEG in these applications is rising.
Monoclonal Antibodies and Proteins: The growing use of monoclonal antibodies (mAbs) and therapeutic proteins in treating chronic diseases like cancer, autoimmune disorders, and genetic conditions is driving demand for PEG, which helps improve the pharmacokinetics of these drugs.
2. Increasing Application in Drug Delivery Systems
Oral, Injectable, and Topical Formulations: PEG is commonly used in various drug delivery systems, including oral, injectable, and topical formulations. Its solubility and ability to improve drug bioavailability make it a preferred excipient in many pharmaceutical products. The rising demand for innovative drug delivery systems is boosting the PEG market.
Controlled and Sustained Release Formulations: PEG is also used in controlled-release formulations to enhance drug stability and modulate the release of active ingredients. As the pharmaceutical industry focuses on developing long-acting formulations, the role of PEG in these systems is expanding.
4. Expansion in the Pharmaceutical Industry
Pharmaceutical Excipients: PEG serves as an important excipient in a wide range of pharmaceutical formulations, including tablets, capsules, and ointments. Its role in improving drug solubility and absorption is critical, particularly for poorly soluble drugs. The continued growth of the pharmaceutical industry, driven by an aging population and the rise in chronic diseases, is contributing to increased demand for pharmaceutical-grade PEG.
Over-the-Counter (OTC) Medications: PEG is commonly used in laxatives and stool softeners. With the increase in the prevalence of gastrointestinal issues and other digestive disorders, particularly in developed markets, the demand for PEG-based OTC medications is growing.
5. Growing Focus on Sustainable and Bio-Based PEG
Sustainability Initiatives: There is an increasing trend toward using bio-based PEG derived from renewable resources due to growing environmental concerns and regulations. Manufacturers are focusing on developing eco-friendly, sustainable alternatives to traditional petrochemical-based PEG, which is expected to gain traction in the pharmaceutical and personal care industries.
Regulatory Compliance: With the tightening of environmental and safety regulations in several regions, the focus on green chemistry and sustainable production methods is becoming more important. Companies investing in the production of bio-based or biodegradable PEG will benefit from this shift.
This report studies the global Pharmaceutical Grade Polyethylene Glycol (PEG) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmaceutical Grade Polyethylene Glycol (PEG) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmaceutical Grade Polyethylene Glycol (PEG) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmaceutical Grade Polyethylene Glycol (PEG) total production and demand, 2021-2032, (Tons)
Global Pharmaceutical Grade Polyethylene Glycol (PEG) total production value, 2021-2032, (USD Million)
Global Pharmaceutical Grade Polyethylene Glycol (PEG) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Pharmaceutical Grade Polyethylene Glycol (PEG) consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Pharmaceutical Grade Polyethylene Glycol (PEG) domestic production, consumption, key domestic manufacturers and share
Global Pharmaceutical Grade Polyethylene Glycol (PEG) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Pharmaceutical Grade Polyethylene Glycol (PEG) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Pharmaceutical Grade Polyethylene Glycol (PEG) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Pharmaceutical Grade Polyethylene Glycol (PEG) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BASF, Dow Chemical, Croda, Clariant, Ineos, India Glycols, Shandong Ruisheng, Jiangxi Yipusheng, Liaoning Huaxing Chemical, Petronas Chemicals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pharmaceutical Grade Polyethylene Glycol (PEG) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market, Segmentation by Type:
Mw (＜1000)
Mw (1000-10000)
Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market, Segmentation by Application:
Tablets
Capsules
Liquids
Injectables
Topicals
Others
Companies Profiled:
BASF
Dow Chemical
Croda
Clariant
Ineos
India Glycols
Shandong Ruisheng
Jiangxi Yipusheng
Liaoning Huaxing Chemical
Petronas Chemicals
Key Questions Answered:
1. How big is the global Pharmaceutical Grade Polyethylene Glycol (PEG) market?
2. What is the demand of the global Pharmaceutical Grade Polyethylene Glycol (PEG) market?
3. What is the year over year growth of the global Pharmaceutical Grade Polyethylene Glycol (PEG) market?
4. What is the production and production value of the global Pharmaceutical Grade Polyethylene Glycol (PEG) market?
5. Who are the key producers in the global Pharmaceutical Grade Polyethylene Glycol (PEG) market?
6. What are the growth factors driving the market demand?
Table of Contents
114 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
